Company intelligence / Profile preview

Jilin Huikang Pharmaceutical

Dunhua, Jilin, China

Ownership: Private
Development stage: Other

Overview

Jilin Huikang Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical drugs. Headquartered in Dunhua, Jilin Province, the company operates several GMP-certified production lines for various formulations, including tablets, capsules, and granules. Its product portfolio primarily addresses cardiovascular health, respiratory infections, and gastrointestinal disorders. Jilin Huikang is recognized for its efforts in modernizing traditional herbal medicine through standardized industrial processes. The company serves the domestic Chinese market, contributing to the regional healthcare infrastructure in Northeast China.

Therapeutic areas: GastroenterologyCardiovascularInfectious Diseases
Modalities: Small moleculeTraditional Chinese Medicine
Industry: Biotech

Beyond the preview

Go deeper on Jilin Huikang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jilin Huikang Pharmaceutical.

Explore the full profile